These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31758950)

  • 1. Container Surfaces Control Initiation of Cavitation and Resulting Particle Formation in Protein Formulations After Application of Mechanical Shock.
    Wu H; Chisholm CF; Puryear M; Movafaghi S; Smith SD; Pokhilchuk Y; Lengsfeld CS; Randolph TW
    J Pharm Sci; 2020 Mar; 109(3):1270-1280. PubMed ID: 31758950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do not drop: mechanical shock in vials causes cavitation, protein aggregation, and particle formation.
    Randolph TW; Schiltz E; Sederstrom D; Steinmann D; Mozziconacci O; Schöneich C; Freund E; Ricci MS; Carpenter JF; Lengsfeld CS
    J Pharm Sci; 2015 Feb; 104(2):602-11. PubMed ID: 25418950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Silicone Oil on Free Fatty Acid Particle Formation due to Polysorbate 20 Degradation.
    Fish R; Lin J; Doshi N
    Pharm Res; 2020 Oct; 37(11):216. PubMed ID: 33029664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Container Surface Passivation on Aggregation of Intravenous Immunoglobulin Induced by Mechanical Shock.
    Movafaghi S; Wu H; Francino Urdániz IM; Bull DS; Kelly MD; Randolph TW; Goodwin AP
    Biotechnol J; 2020 Sep; 15(9):e2000096. PubMed ID: 32437086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlating Surface Activity with Interface-Induced Aggregation in a High-Concentration mAb Solution.
    Escobar ELN; Griffin VP; Dhar P
    Mol Pharm; 2024 Mar; 21(3):1490-1500. PubMed ID: 38385557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material.
    Siska CC; Pierini CJ; Lau HR; Latypov RF; Fesinmeyer RM; Litowski JR
    J Pharm Sci; 2015 Feb; 104(2):447-56. PubMed ID: 25196966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.
    Gerhardt A; Mcumber AC; Nguyen BH; Lewus R; Schwartz DK; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 Dec; 104(12):4056-4064. PubMed ID: 26413998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogel Coatings on Container Surfaces Reduce Protein Aggregation Caused by Mechanical Stress and Cavitation.
    Movafaghi S; Daniels AL; Kelly MD; Witeof AE; Calderon CP; Randolph TW; Goodwin AP
    ACS Appl Bio Mater; 2021 Sep; 4(9):6946-6953. PubMed ID: 35006994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-Polydimethylsiloxane Particles in Liquid Vial Monoclonal Antibody Formulations Containing Poloxamer 188.
    Grapentin C; Müller C; Kishore RSK; Adler M; ElBialy I; Friess W; Huwyler J; Khan TA
    J Pharm Sci; 2020 Aug; 109(8):2393-2404. PubMed ID: 32194095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorption and Aggregation of Monoclonal Antibodies at Silicone Oil-Water Interfaces.
    Kannan A; Shieh IC; Negulescu PG; Chandran Suja V; Fuller GG
    Mol Pharm; 2021 Apr; 18(4):1656-1665. PubMed ID: 33656340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Subvisible Particle Formation in Lyophilized Intravenous Immunoglobulin Formulations Containing Polysorbate 20.
    Zhou C; Qi W; Lewis EN; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Aug; 105(8):2302-9. PubMed ID: 27290624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observation and Mitigation of Lamellar Silica Particles Formed in Pharmaceutical Products Packaged in Glass Vials.
    Nashed-Samuel Y; Gastwirt J; Kotia RB; Moore S; Masatani P; Torraca G; Goss M; Dolan DG; Akers M; Padala C; Wypych J; Semin DJ
    J Pharm Sci; 2022 Dec; 111(12):3275-3286. PubMed ID: 36116524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation and Particle Formation During Pumping of an Antibody Formulation Are Controlled by Electrostatic Interactions Between Pump Surfaces and Protein Molecules.
    Wu H; Randolph TW
    J Pharm Sci; 2020 Apr; 109(4):1473-1482. PubMed ID: 32004539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting Sterilization-Induced Oxidation of Large Molecule Therapeutics Packaged in Plastic Parenteral Vials.
    Vieregg JR; Martin SJ; Breeland AP; Weikart CM; Tirrell MV
    PDA J Pharm Sci Technol; 2018; 72(1):35-43. PubMed ID: 28928291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glass Leachables as a Nucleation Factor for Free Fatty Acid Particle Formation in Biopharmaceutical Formulations.
    Allmendinger A; Lebouc V; Bonati L; Woehr A; Kishore RSK; Abstiens K
    J Pharm Sci; 2021 Feb; 110(2):785-795. PubMed ID: 33035535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parameters Influencing Cavitation Within Vials Subjected to Drop Shock.
    Valotta Rodrigues R; Puryear M; Sederstrom D; Lengsfeld CS
    Sci Rep; 2019 Dec; 9(1):19210. PubMed ID: 31844126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations.
    Gregoritza K; Theodorou C; Heitz M; Graf T; Germershaus O; Gregoritza M
    Eur J Pharm Biopharm; 2024 Jan; 194():74-84. PubMed ID: 38042510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
    Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
    J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Protein Particle Formation in IgG1 mAbs Formulated with PS20 Vs. PS80 When Subjected to Interfacial Dilatational Stress.
    Vaclaw C; Merritt K; Griffin VP; Whitaker N; Gokhale M; Volkin DB; Ogunyankin MO; Dhar P
    AAPS PharmSciTech; 2023 Apr; 24(5):104. PubMed ID: 37081185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.